Disease mongering in drug promotion: do governments have a regulatory role?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16597181.
- Also identified by PMC identifier 1434509.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Most regulatory agencies, says Mintzes, fail to treat regulation of drug promotion as a public health concern. Unless this changes, she says, the public can expect more unfettered disease mongering.
Medical subject headings
- Advertising
- Drug Industry
- Legislation, Drug
- United States Food and Drug Administration